Crossmark

Targeting the Rho/ROCK Signaling Pathway Mitigates Mitochondrial Dysfunction in 6-OHDA-Induced Models of Parkinson’s Disease, Both In Vivo and In Vitro

Crossref DOI link: https://doi.org/10.1007/s12035-025-05419-x

Published Online: 2025-11-17

Published Print: 2026-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Guclu, Ebru https://orcid.org/0000-0001-5330-6159
Inan, Salim Yalcin https://orcid.org/0000-0002-4505-0760
Gunes, Canan Eroglu https://orcid.org/0000-0002-3796-575X
Vural, Hasibe https://orcid.org/0000-0003-2564-7807
Funding

Funding for this research was provided by:

TUBITAK (218S569)
License Information

Text and Data Mining valid from 2025-11-17

Version of Record valid from 2025-11-17
More Information

Article History

Received: 14 May 2025

Accepted: 30 August 2025

First Online: 17 November 2025

Declarations

:

: All experiments involving animals were carried out in accordance with NIH guidelines and were approved by the University of Selcuk Animal Care and Use Committee (Protocol Number: 2018–28).

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below